One of the NCBiotech portfolio companies there is Elysia Bio, founded in 2021 by Raleigh native and CEO Eli Hornstein, Ph.D.
7don MSN
Novel gene editing technology enables selective destruction of cancer cell DNA using fewer targets
Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...
Hosted on MSN
Opinion: Australia has led the way regulating gene technology for over 20 years—here's how it should apply that to AI
Since 2019, the Australian Department for Industry, Science and Resources has been striving to make the nation a leader in "safe and responsible" artificial intelligence (AI). Key to this is a ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...
SAN FRANCISCO--(BUSINESS WIRE)--Kamau Therapeutics ("Kamau" or "the Company"), a clinical-stage gene correction company, announced today its emergence from stealth, following a strategic transaction ...
Viral vectors are engineered viruses that are used to deliver genetic material into cells for various applications, such as gene therapy, vaccine development, and biotechnology research. These viruses ...
First commercially available cell culture solution for HEK293 cells and perfusion - optimized for high cell density (HCD), ...
Most creation myths come with a curse attached. Adam and Eve had to labour for eating that knowledge-giving apple. Prometheus notoriously got a bad time for stealing life-giving fire. And throughout ...
Due to its high accuracy and fast, simple workflow, capillary electrophoresis (CE) is a foundational technology for clinical applications. CE is an invaluable tool used to detect genetic var ...
In a trial run by Verve Therapeutics, a Cambridge–based biotech company, researchers discovered that a single infusion of a gene-editing treatment called VERVE-101 was able to reduce cholesterol ...
The UWA Tech & Policy Lab receives funding from nationally competitive research grants and philanthropic partners. The present research was supported by GA308883: Effective Ethical Frameworks for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results